Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Myelodysplastic Syndromes 87Leukemia 83Leukemia, Myeloid, Acute 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 62Lymphoma 58Leukemia, Lymphocytic, Chronic, B-Cell 57Lymphoma, Non-Hodgkin 53Multiple Myeloma 50Hodgkin Disease 47Myeloproliferative Disorders 45Leukemia, Myeloid, Chronic-Phase 41Lymphoma, Follicular 39Leukemia, Myeloid, Accelerated Phase 39Lymphoma, Mantle-Cell 38Lymphoma, Large B-Cell, Diffuse 38Lymphoma, B-Cell, Marginal Zone 38Burkitt Lymphoma 36Neoplasms, Plasma Cell 33Congenital Abnormalities 33Lymphoma, Large-Cell, Immunoblastic 31Primary Myelofibrosis 28Graft vs Host Disease 28Blast Crisis 28Leukemia, Myelomonocytic, Chronic 27Myelodysplastic-Myeloproliferative Diseases 24Dendritic Cell Sarcoma, Interdigitating 24Anemia, Refractory, with Excess of Blasts 24Recurrence 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Non-Malignant Neoplasm × Antilymphocyte Serum × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡